CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
in patients ≥ 6 to \< 18 years of age with severe eosinophilic asthma, including a well-documented history of asthma exacerbations ...
Phase 3
Kansas City, Missouri, United States and 83 other locations
This is a US study comparing the efficacy and safety of BDA MDI \[Budesonide/Albuterol Sulfate (BDA) metered dose inhaler (MDI)\] with AS \[Albuterol...
Phase 3
Kansas City, Missouri, United States and 60 other locations
and formoterol fumarate metered dose inhaler relative to budesonide metered dose inhaler in adults and adolescents with inadequately controlled asthma...
Phase 3
Kansas City, Missouri, United States and 138 other locations
with amlitelimab in adult participants with moderate-to-severe asthma.Study details include:* The study duration (per participant) will be u...
Phase 2
Kansas City, Kansas, United States and 122 other locations
inhaler (eMDPI) compared to ABS eMDPI in decreasing severe clinical asthma exacerbation (CAEs).Secondary Objectives:To evaluate the efficacy...
Phase 3
Overland Park, Kansas, United States and 156 other locations
and safety of Atuliflapon administered once daily over a 12-week treatment period to adult participants with moderate to severe uncontrolled asthma...
Phase 2
Leawood, Kansas, United States and 369 other locations
of clinically significant exacerbations in participants with severe asthma with an eosinophilic phenotype. Throughout the study, all partici...
Phase 3
Overland Park, Kansas, United States and 429 other locations
The purpose of the study is to evaluate effect of benralizumab on structural and lung function changes in severe eosinophilic asthmatics.Changes will...
Phase 4
Kansas City, Kansas, United States and 44 other locations
Clinical trials
Research sites
Resources
Legal